Steve Holtzclaw, MD, serves as CEO of U.S. Orthopaedic Partners, an orthopedic services management organization. Dr. Holtzclaw stepped into the role in January 2024. USOP, which was first established ...

Steven R. Sarkisian Jr., MD, ABO, presented data from an FDA clinical trial of a travopost intracameral implant. The iDose TR (Glaukos) is indicated for reduction of intraocular pressure (IOP) using a ...